You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 252 No. 19, November 16, 1984 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Scientific challenges in the application of randomized trials

M. S. Kramer and S. H. Shapiro

In recent years, scientific challenges in the application of randomized trials have become more apparent, especially with the extension of such trials to the assessment of nondrug treatments, such as health education, psychotherapy, and health care provision. Six issues (individual v group randomization, blinding and unblinding, the effect of trial participation on outcome, selective subject participation, treatment compliance, and standardized v individualized treatment) are discussed in terms of their impact on internal validity, generalizability (external validity), and clinical relevance. Specific design strategies may be necessary to enhance these methodological and clinical desiderata. Attention to these challenges should lead to improvements in future randomized trials.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Using causal models to show the effect of untestable assumptions on effect estimates in randomized controlled trials
Allard and Boivin
Clin Trials 2007;4:611-620.
ABSTRACT  

A Technical Infrastructure to Conduct Randomized Database Studies Facilitated by a General Practice Research Database
Mosis et al.
J. Am. Med. Inform. Assoc. 2005;12:602-607.
ABSTRACT | FULL TEXT  

Scaling Up HIV Voluntary Counseling and Testing in Africa: What Can Evaluation Studies Tell Us About Potential Prevention Impacts?
Glick
Eval Rev 2005;29:331-357.
ABSTRACT  

Race and Electronically Measured Adherence to Immunosuppressive Medications after Deceased Donor Renal Transplantation
Weng et al.
J. Am. Soc. Nephrol. 2005;16:1839-1848.
ABSTRACT | FULL TEXT  

Epidemiology and clinical aspects of congestive heart failure
Murray-Thomas and Cowie
Journal of Renin-Angiotensin-Aldosterone System 2003;4:131-136.
ABSTRACT  

Randomised controlled trials in the evaluation of non-biomedical therapeutic interventions for pain: The gold standard?
Walker and Sofaer
Journal of Research in Nursing 2003;8:317-329.
ABSTRACT  

Cognitive Rehabilitation Following Traumatic Brain Injury
Jordan
JAMA 2000;283:3123-3124.
FULL TEXT  

Treatment Research at the Crossroads: The Scientific Interface of Clinical Trials and Effectiveness Research
Wells
Am. J. Psychiatry 1999;156:5-10.
ABSTRACT | FULL TEXT  

Investigating Alternative Medicine Therapies in Randomized Controlled Trials
Margolin et al.
JAMA 1998;280:1626-1628.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.